Mera Pharmaceuticals, Inc. (MRPI)

Mera Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2011	FY 2010	FY 2009
Period Ending	Jul 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2011	Oct 31, 2010	Oct 31, 2009
Revenue	-	-	-	0.3	0.29	0.6
Revenue Growth (YoY)	-	-	-	4.75%	-51.78%	-1.79%
Cost of Revenue	-	-	-	0.02	0.05	0.03
Gross Profit	-	-	-	0.29	0.24	0.57
Selling, General & Admin	0.01	0.01	0.01	0.31	0.19	0.36
Research & Development	-	-	-	0.17	0.27	0.32
Operating Expenses	0.01	0.01	0.01	0.49	0.48	0.77
Operating Income	-0.01	-0.01	-0.01	-0.2	-0.24	-0.2
Interest Expense	-	-	-	-0.01	-0	-0.01
Interest & Investment Income	-	-	-	-	-	0
Other Non Operating Income (Expenses)	-	-	-	0	-0	-
EBT Excluding Unusual Items	-0.01	-0.01	-0.01	-0.2	-0.24	-0.2
Asset Writedown	-	-	-	-	-0.31	-0.02
Other Unusual Items	-	-	-	-	-	0
Pretax Income	-0.01	-0.01	-0.01	-0.2	-0.56	-0.22
Income Tax Expense	-	-	-	-0.01	-0.02	-0.03
Net Income	-0.01	-0.01	-0.01	-0.19	-0.54	-0.19
Preferred Dividends & Other Adjustments	-	-	-	0.03	0.03	0.03
Net Income to Common	-0.01	-0.01	-0.01	-0.22	-0.57	-0.23
Shares Outstanding (Basic)	557	557	557	548	548	547
Shares Outstanding (Diluted)	557	557	557	548	548	547
Shares Change (YoY)	1.83%	-	1.74%	-	0.09%	5.89%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-	-	-	-0.07	-0.14	-0.05
Gross Margin	-	-	-	94.63%	84.05%	95.32%
Operating Margin	-	-	-	-66.44%	-82.14%	-33.69%
Profit Margin	-	-	-	-72.90%	-197.58%	-37.69%
Free Cash Flow Margin	-	-	-	-24.49%	-48.96%	-8.44%
EBITDA	-	-	-	-0.19	-0.21	-0.12
EBITDA Margin	-	-	-	-63.69%	-72.44%	-19.56%
D&A For EBITDA	-	-	-	0.01	0.03	0.08
EBIT	-0.01	-0.01	-0.01	-0.2	-0.24	-0.2
EBIT Margin	-	-	-	-66.44%	-82.14%	-33.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.